2020 Meetings Abstracts: AACR Special Conference on Advancing Precision Medicine Drug Development: Incorporation of Real-World Data and Other Novel Strategies January 9–12, 2020; San Diego, CA ...
You do not currently have access to this content.
Cancer Res (2022) 82 (12_Supplement): 3597.
Mol Cancer Ther (2025) 24 (10_Supplement): B116.
Mol Cancer Ther (2023) 22 (12_Supplement): A023. Conclusions:Lunresertib and the WEE1 inhibitor Debio-0123 elicit strong synergistic activity in preclinical models of CCNE1-overexpressoin due to rapid ...
NOTICE: This notice serves to inform the reader that, in 2023, AACR received a donation by Pfizer of the rights to royalties from the sale—within the United States—of Bavencio ® (avelumab), a ...
Mol Cancer Ther (2023) 22 (12_Supplement): A085.
Cancer Res (2025) 85 (8_Supplement_1): 6376.
KRAS pathways are frequently upregulated in cancers bearing KRAS mutations or by other signaling modifications. Also, resistance to KRAS G12C inhibitors and other KRAS/RAF/MEK pathway drugs is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results